— Know what they know.
Not Investment Advice
Also trades as: AB.PA (PAR) · $vol 0M · 0Q77.L (LSE) · $vol 0M

ABSCF OTC

AB Science S.A.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -22.8% 1Y: -11.1% 3Y: -84.5% 5Y: -91.2%
$1.12
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 40 · $82.0M mcap · 66M float · 0.0000% daily turnover · Short 100% of daily vol

Balance Sheet Trends

Total Assets
$23M -9.1% ▼
5Y CAGR: +5.5%
Total Liabilities
$47M +0.9% ▲
5Y CAGR: +1.0%
Shareholders Equity
-$24M -13.1% ▼
Cash & Investments
$8M +31.7% ▲
5Y CAGR: +7.0%
Total Debt
$18M -3.3% ▼
5Y CAGR: +55.6%
Net Debt
$10M -19.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$21M$9M$7M$6M$8M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$21M$9M$7M$6M$8M
Net Receivables$738K$632K$683K$793K$827K
Inventory$79K$141K$456K$336K$184K
Other Current Assets$5M$8M$12M$12M$5M
Total Current Assets$26M$18M$21M$19M$15M
Property, Plant & Equip.$2M$2M$1M$785K$899K
Goodwill & Intangibles$1M$1M$2M$1M$1M
Long-Term Investments$67K$67K$74K$84K$0
Other Non-Current Assets$69K$71K$77K$4M$6M
Total Non-Current Assets$3M$3M$3M$6M$9M
Total Assets$30M$21M$24M$25M$23M
— Liabilities —
Accounts Payable$13M$6M$7M$6M$6M
Short-Term Debt$4M$250K$4M$2M$4M
Deferred Revenue$847K$2M$10M$0$0
Other Current Liabilities-$295K-$343K-$8M$2M$10M
Total Current Liabilities$23M$17M$23M$19M$20M
Long-Term Debt$938K$7M$22M$17M$14M
Other Non-Current Liab.$24M$19M$13M$11M$12M
Total Non-Current Liabilities$27M$27M$36M$28M$26M
Total Liabilities$49M$44M$60M$47M$47M
— Equity —
Common Stock$459K$469K$469K$511K$579K
Retained Earnings$0$0$0$0$0
Accumulated OCI-$245M-$258M-$270M-$287M-$296M
Total Stockholders Equity-$20M-$23M-$36M-$21M-$24M
Total Liabilities & Equity$30M$21M$24M$25M$23M
— Key Metrics —
Total Debt$7M$8M$28M$19M$18M
Net Debt-$14M-$369K$20M$13M$10M
Total Investments$67K$67K$74K$84K$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms